Snapshot A 59-year-old woman with recently diagnosed metastatic estrogen-receptor (ER) positive and human epidermal growth factor 2 (HER2) negative breast cancer presents for follow-up care. She is hormone therapy naive and has non-visceral involvement of the cancer. She is started on letrozole. Introduction Mechanism of action login to view 1 more bullet Clinical use login to view 2 more bullets Toxicity login to view 2 more bullets Medications login to view 3 more bullets